Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says - WSJ
Company plans to refile its application for its gene therapy for a fatal brain disease after FDA dropped demands to give a placebo to some study subjects... Read More
Source: The Wall Street Journal
Published: 2026-06-22T11:23:00Z
Author: Xavier Martinez